Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Debt-to-equity ratio
| Period | Value | Change |
|---|---|---|
| 2024 | 0.03 | -31.1% |
| 2023 | 0.05 | -12.4% |
| 2022 | 0.05 | +74.8% |
| 2021 | 0.03 | -23.6% |
| 2020 | 0.04 | -13.1% |
| 2019 | 0.05 | +89.5% |
| 2018 | 0.02 | +156.1% |
| 2017 | 0.01 | -72.1% |
| 2016 | 0.03 | -82.2% |
| 2015 | 0.19 | - |